Skip to content

Clinical trials

Phase 3 Fibrosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Phase 3 Country / region: Australia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20092
20121
20142
20161
20211
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
Vertex Pharmaceuticals Incorporated2
AbbVie1
Bristol-Myers Squibb1
Genfit1
Gilead Sciences1
Intercept Pharmaceuticals1
Inventiva Pharma1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis11
Non-alcoholic Fatty Liver Disease4
Digestive System Diseases3
Liver Diseases3
Cystic Fibrosis2
Fatty Liver2
Genetic Diseases, Inborn2
Hepatitis C2
Infant, Newborn, Diseases2
Lung Diseases2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.